CDKN2AIP and neoplasm: Notably, as our study was generally based onin vitro tumor cell line models and retrospective clinical cohorts, the conclusions drew from our research should be further confirmed in future studies with expanded scale.In vivo animal models with CDKN2AIP gene knock-down combined with perspective multi-centered clinical studies are also warranted for future explorations.